Literature DB >> 22036232

Pre-ART HIV resistance testing in Africa: are we there yet?

Andrew Kambugu1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22036232     DOI： 10.1016/S1473-3099(11)70280-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  What is the optimal first line antiretroviral therapy in resource-limited settings?

Authors:  Chris Kenyon; Robert Colebunders
Journal:  PLoS Med       Date:  2012-08-14       Impact factor: 11.069

2.  Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.

Authors:  Jane E Greig; Philipp A du Cros; Clair Mills; Wilfred Ugwoeruchukwu; Andrew Etsetowaghan; Adetola Grillo; Adetoro Tayo-Adetoro; Kunle Omiyale; Tim Spelman; Daniel P O'Brien
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

3.  Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.

Authors:  More Mungati; Mutsa Mhangara; Elizabeth Gonese; Owen Mugurungi; Janet Dzangare; Stella Ngwende; Patience Musasa; Maureen Wellington; Gerald Shambira; Tsitsilina Apollo; Chunfu Yang; Joshua DeVos; Jennifer Sabatier; Peter Kilmarx; Christine Chakanyuka-Musanhu; Mufuta Tshimanga
Journal:  BMC Res Notes       Date:  2016-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.